Cargando…
Cell-based medicinal products and the development of GMP-compliant processes and manufacturing
Autores principales: | Romagnoli, Luca, Giuntini, Ilaria, Galgano, Marta, Crosta, Chiara, Cavenaghi, Luigi, Nolli, Maria Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284923/ https://www.ncbi.nlm.nih.gov/pubmed/22373285 http://dx.doi.org/10.1186/1753-6561-5-S8-O3 |
Ejemplares similares
-
cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015) -
NO/GMP as mediators of estrogen effects in bone
por: Kalyanaraman, Hema, et al.
Publicado: (2015) -
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
por: Boudousquié, Caroline, et al.
Publicado: (2020) -
MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process
por: Lechanteur, Chantal, et al.
Publicado: (2021) -
Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
por: Landauer, Karlheinz, et al.
Publicado: (2011)